Skip to main content
Fig. 3 | Cancer Nanotechnology

Fig. 3

From: Evaluation of the performance of Fe3O4/MnO2@doxorubicin hybrid nanozymes on multicellular structure and their therapeutic management to limit the growth of human breast cancer cells

Fig. 3

A Drug loading and its efficiency. B Thermogravimetric analysis of FMHN and FMDHN, and their weight loss between 70 and 450 °C heating. C Magnetization curves at room temperature for Fe3O4 nanozymes, FMHN and FMDHN. D Quantitative analyses of DOX release at 37 °C at different pH with and without PTT. E O2 generation in H2O2 solution with Fe3O4 nanozymes, FMHN and FMDHN with and without PTT. F Fluorescence spectra of terephthalic acid incubated with Fe3O4 nanozymes, FMHN, FMDHN with and without PTT in the hypoxic condition to show the presence of ·OH

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us